SPDR Gold MiniShares Trust (GLDM)
Live price chart, market sentiment, and community perspectives for SPDR Gold MiniShares Trust (AMEX: GLDM).
Live price chart, market sentiment, and community perspectives for SPDR Gold MiniShares Trust (AMEX: GLDM).
On our desk, GLDM remains the go-to vehicle for liquid physical gold exposure given its tight 0.10% expense ratio and massive $30.48 billion AUM base. However, looking at the recent technicals from mid-2026—specifically the 50-day moving average dropping below the 200-day moving average—we are maintaining a cautious stance on near-term entry points. While automated wealth management tools like Wealthfront utilize it cleanly for tax-loss harvesting against alternatives like GLTR, tactical momentum indicators suggest waiting for consolidation before scaling aggressively.
From a risk management standpoint, investors need to remember that GLDM is treated as a collectible for tax purposes, introducing tax-inefficiencies that standard equity ETFs avoid. Furthermore, while short interest is very low at roughly 1.6% of the float (3.4 million shares), recent price action has tested investors with a 52-week range stretching from $65.64 to $109.74. With a beta of 0.76 and a low correlation of 0.16 to the broad SPY ETF, it behaves as advertised as a true diversifier, but short-term volatility driven by macroeconomic rate expectations requires strict adherence to stop-loss guidelines.
When evaluating the structural mechanics of the trust for institutional clients, we look closely at its setup as a series of the World Gold Trust sponsored by WGC USA Asset Management Company, LLC. Trading on NYSE Arca, its custody arrangements and commodity contract focus provide clean tracking against the LBMA Gold Price PM benchmark. Analysts evaluating the fund should note that despite recent QTD and YTD drawdowns hovering around -12.66% and -6.58% respectively as of July 2026, the long-term annualized returns since inception in June 2018 remain solid at over 15%.
Explore plasma cleansing, somatic organ swaps, and BCI.